Table 2. Positive rate of anti-CagA IgG, IgA, and IgM according to age and year.
| Age | IgG, % | P value | IgA, % | P value | IgM, % | P value | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1994–1995 | 2004–2005 | 2014–2015 | 1994–1995 | 2004–2005 | 2014–2015 | 1994–1995 | 2004–2005 | 2014–2015 | ||||
| Neonate | 73.7 | 75.0 | 63.2 | 0.765 | 10.5 | 30.0 | 0.0 | 0.021 | 0.0 | 15.0 | 0.0 | 0.100 |
| 1–6 mon | 55.0 | 55.0 | 25.0 | 0.112 | 0.0 | 5.0 | 0.0 | 1.000 | 0.0 | 5.0 | 0.0 | 1.000 |
| 7–12 mon | 50.0 | 31.6 | 0.0 | < 0.001 | 0.0 | 5.3 | 0.0 | 0.317 | 0.0 | 0.0 | 0.0 | - |
| 13–24 mon | 45.0 | 15.0 | 15.0 | 0.063 | 15.0 | 5.0 | 0.0 | 0.310 | 0.0 | 0.0 | 0.0 | - |
| 2–4 yr | 25.0 | 17.5 | 13.9 | 0.484 | 2.5 | 2.5 | 5.6 | 0.686 | 0.0 | 0.0 | 0.0 | - |
| 5–9 yr | 35.0 | 22.5 | 15.0 | 0.132 | 12.5 | 12.5 | 12.5 | 1.000 | 0.0 | 7.5 | 2.5 | 0.322 |
| 10–14 yr | 60.0 | 35.9 | 12.5 | < 0.001 | 27.5 | 30.8 | 10.0 | 0.047 | 2.5 | 0.0 | 5.0 | 0.772 |
| 15–19 yr | 85.0 | 52.5 | 17.5 | < 0.001 | 40.0 | 35.0 | 17.5 | 0.081 | 2.5 | 0.0 | 10.0 | 0.125 |
| 20–29 yr | 80.0 | 72.5 | 28.9 | < 0.001 | 30.0 | 52.5 | 24.4 | 0.022 | 2.5 | 12.5 | 15.6 | 0.109 |
| 30–39 yr | 85.0 | 77.5 | 62.5 | 0.070 | 67.5 | 50.0 | 55.0 | 0.259 | 7.5 | 32.5 | 12.5 | 0.010 |
| 40–49 yr | 62.5 | 77.5 | 82.5 | 0.107 | 27.5 | 50.0 | 52.5 | 0.049 | 5.0 | 20.0 | 20.0 | 0.083 |
| 50–59 yr | 72.5 | 92.5 | 89.5 | 0.034 | 67.5 | 72.5 | 84.2 | 0.216 | 27.5 | 22.5 | 21.1 | 0.859 |
| ≥ 60 yr | 72.5 | 69.0 | 75.0 | 0.829 | 57.5 | 48.3 | 62.5 | 0.492 | 22.5 | 13.8 | 20.0 | 0.749 |
Statistically significant differences according to age and study period are shown in bold.
CagA = cytotoxic-associated gene A, Ig = immunoglobulin.